Patents

Evox has been granted US Patent US11,640,272. The claims of this patent cover a method of purifying engineered exosomes via a downstream process utilizing ultrafiltration and size-based separation...

ExoCoBio announced that it has obtained a patent (US Application No: 17/141,693) from the US Patent and Trademark Office for a cosmetic composition...

NurExone Biologic Inc, a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, announces that the Company has received an issue...

The patent covers Nurexone’s ExoPTEN drug compositions and treatment methods for Central Nervous System disease NurExone Biologic Inc, a biopharmaceutical company developing biologically...

Evox Therapeutics, a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad...

ExoCoBio, one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims that stem cell-derived exosome is proved as effective ingredient for...

Aptorum Group Limited, a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and Trademark Office (“US PTO”) has granted the patent regarding the Rapid Pathogen Infectious Disease Liquid Biopsy Diagnostics...

Newly issued patent covers proprietary approach for loading nucleic acids into exosomes Evox Therapeutics, a leading exosome therapeutics company, today announced that the Company has...

A Korean genetic sequencing firm has taken a step towards the commercialization of its liquid biopsy technology, which aims at detecting early stage cancer with a simple blood test and suggesting optimized treatment. Eone Diagnomics Genome Center (EDGC) announced that ...

Creative Medical Technology Holdings announced today filing a new patent application covering nanoparticles called “exosomes” secreted by cells of its...